cabozantinib,atezolizumab
roche,exelixis
['9005', 'cosmic 021', 'pdl']
abst 9005; cabozantanib + atezo. cosmic 021; not an rct; orr 19 v 6%; orr lower in pdl1 neg. hypothesis generating . #asco22 
Consultant Medical Oncologist, UK. Views are hypothesis generating discourse. Post COVID dabbling in garden.